Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13136
Country/Region: Uganda
Year: 2016
Main Partner: Makerere University
Main Partner Program: Infectious Disease Institute
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 40
GEND_GBV Age/Sex: <10 Male 2017 24
GEND_GBV Age/Sex: 10-14 Female 2017 116
GEND_GBV Age/Sex: 10-14 Male 2017 24
GEND_GBV Age/Sex: 15-19 Female 2017 207
GEND_GBV Age/Sex: 15-19 male 2017 42
GEND_GBV Age/Sex: 20-24 Female 2017 211
GEND_GBV Age/Sex: 20-24 Male 2017 40
GEND_GBV Age/Sex: 25-49 Female 2017 83
GEND_GBV Age/Sex: 25-49 Male 2017 40
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 73
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 182
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 645
GEND_GBV Number of people receiving post-GBV care 2017 827
GEND_GBV Sum of Age/Sex Disaggregates 2017 204
HTS_TST Age/sex: <1 2017 1,018
HTS_TST Age/sex: 1-9 2017 3,353
HTS_TST Age/sex: 10-14 Female 2017 2,894
HTS_TST Age/sex: 10-14 Male 2017 2,893
HTS_TST Age/sex: 15-19 Female 2017 7,594
HTS_TST Age/sex: 15-19 Male 2017 6,134
HTS_TST Age/sex: 20-24 Female 2017 11,390
HTS_TST Age/sex: 20-24 Male 2017 9,203
HTS_TST Age/sex: 25-49 Female 2017 17,465
HTS_TST Age/sex: 25-49 Male 2017 14,110
HTS_TST Age/sex: 50+ Female 2017 1,517
HTS_TST Age/sex: 50+ Male 2017 1,227
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 5,080
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 5,078
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 37,966
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 30,674
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 78,798
HTS_TST Service Delivery Point (Facility): Index testing 2017 8,000
HTS_TST Service Delivery Point (Facility): Inpatient 2017 23,735
HTS_TST Service Delivery Point (Facility): Other PITC 2017 4,557
HTS_TST Service Delivery Point (Facility): Outpatient 2017 16,447
HTS_TST Service Delivery Point (Facility): Pediatric 2017 8,995
HTS_TST Service Delivery Point (Facility): PMTCT 2017 14,606
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,132
HTS_TST Service Delivery Point (Facility): VMMC 2017 1,326
HTS_TST Sum of Age/Sex disaggregates 2017 74,427
HTS_TST Sum of Aggregated Age/Sex <15 2017 10,158
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 68,640
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 78,798
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 142
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 144
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 414
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 263
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 622
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 394
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 953
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 604
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 84
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 52
HTS_TST_POS Test Result by Age: Positive: <1 2017 51
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 170
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 254
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 253
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 2,073
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,313
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 7
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 50
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 57
KP_PREV Total estimated number of key population in the catchment area 2017 156
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 90
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 21
KP_PREV_den By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 45
PMTCT_ART Already on ART at beginning of current pregnancy 2017 822
PMTCT_ART New on ART 2017 589
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 14,745
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 931
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 262
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 11
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 48
PMTCT_EID Sum of Infant Age disaggregates 2017 1,193
PMTCT_STAT By: Known positives at entry 2017 962
PMTCT_STAT By: Number of new positives identified 2017 530
PMTCT_STAT Number of new ANC and L&D clients 2017 15,125
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 14,745
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,492
PP_PREV Aggregated Age/sex: <15 Female 2017 16
PP_PREV Aggregated Age/sex: <15 Male 2017 14
PP_PREV Aggregated Age/sex: 15+ Female 2017 17
PP_PREV Aggregated Age/sex: 15+ Male 2017 17
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 61
PP_PREV Total number of people in the target population 2017 1,127
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 65
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 113
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 181
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 181
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 3,534
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 352
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1,060
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 2,122
TB_SCREENDX Screen Result: Screened Positive for TB 2017 883
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 27,772
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 14,285
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 1,118
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 981
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 44,156
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 10
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 130
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 12
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 228
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 380
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 380
TX_CURR Age/Sex: <1 2017 83
TX_CURR Age/Sex: <1-9 2017 504
TX_CURR Age/Sex: 10-14 Female 2017 816
TX_CURR Age/Sex: 10-14 Male 2017 696
TX_CURR Age/Sex: 15-19 Female 2017 1,390
TX_CURR Age/Sex: 15-19 Male 2017 430
TX_CURR Age/Sex: 20-24 Female 2017 6,387
TX_CURR Age/Sex: 20-24 Male 2017 2,856
TX_CURR Age/Sex: 25-49 Female 2017 18,605
TX_CURR Age/Sex: 25-49 Male 2017 10,284
TX_CURR Age/Sex: 50+ Female 2017 1,390
TX_CURR Age/Sex: 50+ Male 2017 715
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,118
TX_CURR Aggregated Age/Sex: <15 Male 2017 981
TX_CURR Aggregated Age/Sex: 15+ Female 2017 27,772
TX_CURR Aggregated Age/Sex: 15+ Male 2017 14,285
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 44,156
TX_CURR Sum of age/sex disaggregates 2017 1,820
TX_CURR Sum of Aggregated Age/Sex <15 2017 2,099
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 42,057
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 44,156
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 316
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 281
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 3,740
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,930
TX_NEW By Age/Sex: <1 2017 22
TX_NEW By Age/Sex: 1-9 2017 145
TX_NEW By Age/Sex: 10-14 Female 2017 231
TX_NEW By Age/Sex: 10-14 Male 2017 199
TX_NEW By Age/Sex: 15-19 Female 2017 188
TX_NEW By Age/Sex: 15-19 Male 2017 57
TX_NEW By Age/Sex: 20-24 Female 2017 861
TX_NEW By Age/Sex: 20-24 Male 2017 387
TX_NEW By Age/Sex: 25-49 Female 2017 2,506
TX_NEW By Age/Sex: 25-49 Male 2017 1,390
TX_NEW By Age/Sex: 50+ Female 2017 185
TX_NEW By Age/Sex: 50+ Male 2017 96
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 6,267
TX_NEW Sum of Age/Sex disaggregates 2017 6,100
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 6,267
VMMC_CIRC By Age: 10-14 2017 517
VMMC_CIRC By Age: 15-19 2017 384
VMMC_CIRC By Age: 20-24 2017 185
VMMC_CIRC By Age: 25-29 2017 106
VMMC_CIRC By Age: 30-49 2017 106
VMMC_CIRC By Age: 50+ 2017 28
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 1,326
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 1,326
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 1,326
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 1,114
Mechanism Allocation by Budget Code for Selected Year
5.5%7.3%9.1%10.9%12.7%14.5%16.4%18.2%0-101234567891011HBHCHKIDHVTBPDCSHLABCIRCHVCTHVOPMTCTHTXSPDTX
Planned Funding by Program Area over Known Duration of Mechanism
201120122013201420152016$0$500,000$1,000,000$1,500,000$2,000,000$2,500,000$3,000,000$3,500,000$4,000,000$4,500,000$5,000,000$5,500,000CareGovernance and SystemsPreventionTestingTreatment